Your browser doesn't support javascript.
loading
Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis.
Nakamura, Yuto; Fukutomi, Yuma; Sekiya, Kiyoshi; Kajiwara, Keiichi; Kawasaki, Yuichiro; Fujita, Norihiro; Nagayama, Kisako; Iwata, Maki; Iwamoto, Keisuke; Yano, Koichi; Hamada, Yuto; Watai, Kentaro; Ryu, Kai; Hayashi, Hiroaki; Kamide, Yosuke; Taniguchi, Masami.
Afiliação
  • Nakamura Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Fukutomi Y; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Sekiya K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Kajiwara K; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kawasaki Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Fujita N; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Nagayama K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Iwata M; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Iwamoto K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Yano K; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Hamada Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Watai K; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Ryu K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Hayashi H; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Kamide Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Taniguchi M; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Mod Rheumatol ; 32(2): 387-395, 2022 Feb 28.
Article em En | MEDLINE | ID: mdl-34910206
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Churg-Strauss / Granulomatose com Poliangiite / Doenças do Sistema Nervoso Periférico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mod Rheumatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Churg-Strauss / Granulomatose com Poliangiite / Doenças do Sistema Nervoso Periférico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mod Rheumatol Ano de publicação: 2022 Tipo de documento: Article